Followers | 2 |
Posts | 62 |
Boards Moderated | 0 |
Alias Born | 07/02/2013 |
Thursday, June 04, 2020 3:36:19 PM
SK was always treated as a side project, so they aren't focusing much energy on it. They even said so. AGN is focusing entirely on the multinational trial.
CEO explained in last webcast why they do halts, "to let people digest news and make it fair".
Dramatic for a US company? definitely. Companies are pumping out stuff mid day all the time unless it's insanely big news.
Dramatic for a Canadian company? No idea, unless anyone trades there normally and knows the typical behavior.
I did not expect a big share movement today. All in all, getting FDA approval just means it is countdown until data. Whereas the beginning of the countdown was somewhat a little more murky beforehand.
You can either flip pennies, or you can just wait on the data, who cares what happens in between. The final SP will reflect the data, whether 0.05 or $5.00, anything in between is a waste of time unless you're flipping.
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM